Condition: Left Ventricular Thrombus · Acute Myocardial Infarction · Sponsor: Karolinska Institutet
The optimal anticoagulant for the treatment of left ventricular (LV) thrombus following acute myocardial infarction (AMI) is unclear. The aim of this multicenter randomized study is to evaluate the efficacy of apixaban versus warfarin with respect to thrombus resolution in patients with LV thrombus after AMI.
This description comes directly from the study's public registry record.
Eva Olofsson · +46707780897 · moa.simonsson@ki.se
Stina Smetana · +46725841182 · stina.smetana@ki.se
Always discuss trial participation with your own doctor first.
| Falu lasarett | Falun, Sweden | Not Yet Recruiting |
| Sahlgrenska University hospital, Mölndal | Gothenburg, Sweden | Not Yet Recruiting |
| Sahlgrenska University hospital, Östra | Gothenburg, Sweden | Not Yet Recruiting |
| Sahlgrenska University hospital | Gothenburg, Sweden | Not Yet Recruiting |
| Linköping University hospital | Linköping, Sweden | Not Yet Recruiting |
| Skånes Universitetssjukhus Lund | Lund, Sweden | Recruiting |
| Skånes University hospital, Malmö | Malmö, Sweden | Not Yet Recruiting |
| Vrinnevi hospital | Nörrköping, Sweden | Not Yet Recruiting |
| Örebro University hospital | Örebro, Sweden | Not Yet Recruiting |
| Karolinska Insitutet | Stockholm, Sweden | Recruiting |
| Danderyds hospital | Stockholm, Sweden | Not Yet Recruiting |
| Karolinska Univerity Hospital | Stockholm, Sweden | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06515730